About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials LymphomaTexas

Lymphoma Clinical Trials in Texas

Find 1,133 clinical trials for lymphoma near Texas. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 501-520 of 1,133 trials

TerminatedA Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin LymphomaThe purpose of this phase 2 study is to evaluate the efficacy and safety of NIR178 in combination with PDR001 in multiple solid tumors and diffuse large B-cell lymphoma (DLBCL)…NCT03207867·Santa Monica, California and 20 others CompletedCompare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular LymphomaThe primary objective of the current study is to demonstrate the equivalent efficacy of rituximab (DRL\_RI) and MabThera® in subjects with Low Tumor Burden Follicular Lymphoma…NCT03976102·Whittier, California and 3 others

PreviousPage 26 of 57Next

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingA Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular LymphomaThe purpose of this study is to learn about the safety and effects of the study medicine (called Mevrometostat) for the possible treatment of Relapsed/ Refractory Small Cell Lung…NCT03460977·Tucson, Arizona and 83 others

CompletedRituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)This study is designed as a Phase III, multicenter trial, comparing progression-free survival (PFS) after autologous hematopoietic stem cell transplantation using a standard…NCT00329030·New Haven, Connecticut and 35 others

RecruitingStudy of VIP943 in Subjects With Advanced CD123+ Hematologic MalignanciesDose Escalation - Determine the maximum tolerated dose (MTD), if possible, or minimum optimal biologic dose (OBD), and evaluate the safety and tolerability of VIP943 in subjects…NCT06034275·Birmingham, Alabama and 4 others

RecruitingCaloric Restriction and Activity to Reduce Chemoresistance in B-ALLThis study is for older children, adolescents, and young adults with B-cell Acute Lymphoblastic Leukemia (B-ALL).NCT05082519·Los Angeles, California and 15 others

CompletedThe Second Multicenter Hemophilia Cohort StudyThe Second Multicenter Hemophilia Cohort Study (MHCS-II) will evaluate and prospectively follow approximately 4500 persons with hemophilia who were exposed to hepatitis C virus…NCT00341705·Tucson, Arizona and 47 others

TerminatedA Study of PLX51107 in Advanced MalignanciesThe purpose of this research study is to evaluate safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of the investigational drug PLX51107 in subjects with…NCT02683395·New York, New York and 4 others

TerminatedOpen-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesThe purpose of the Study is to select a dose and assess the safety and tolerability of INCB057643 as a monotherapy (Part 1 and Part 2) and in combination with standard-of-care…NCT02711137·Birmingham, Alabama and 17 others

CompletedPatient Registry to Observe Outcomes Following Implantation of the VariLift Interbody Fusion DeviceThe registry has been designed as a prospective, observational program for patients undergoing lumbar or cervical fusion using VariLift device with the ultimate goal to aid in the…NCT01944345·Boston, Massachusetts and 2 others

RecruitingA Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other…NCT01351545·Birmingham, Alabama and 141 others

WithdrawnStudy of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)This is a Phase 1/2, multicenter, open-label study to evaluate the efficacy, and safety of various combinations with selinexor in participants with RR DLBCL.NCT04607772·Tucson, Arizona and 17 others

CompletedDexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell LymphomaRATIONALE: Denileukin diftitox may be able to deliver cancer-killing substances directly to T-cell lymphoma cells.NCT00006345·Miami, Florida and 10 others

Active not recruitingStudy of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell TransplantThis study will evaluate pediatric patients with malignant or non-malignant blood cell disorders who are having a blood stem cell transplant depleted of T cell receptor (TCR) alfa…NCT03301168·Los Angeles, California and 9 others

CompletedStudy to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.The main purpose of this first human study with CC-115 is to assess the safety and action of a new class of experimental drug (dual DNA-PK and TOR kinase inhibitors) in patients…NCT01353625·Los Angeles, California and 16 others

CompletedStudy Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell LymphomaStudy of Yttrium-ibritumomab (Zevalin) For the treatment of Patients with Relapsed \& Refractory Mantle Cell LymphomaNCT00038623·Houston, Texas

TerminatedA Clinical Study of ONCT-808 in Subjects With Relapsed or Refractory B-Cell MalignanciesThis is a Phase 1/2 study to investigate the safety and efficacy of the CAR-T therapy, ONCT-808, in patients with relapsed/refractory (R/R) aggressive B cell malignancies.NCT05588440·Duarte, California and 3 others

CompletedTotal-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerRATIONALE: Radiation therapy uses high-energy x-rays to damage cancer cells.NCT00044954·Denver, Colorado and 13 others

CompletedA Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or LymphomasDS-3078a will be evaluated as a single agent in subjects with advanced solid tumor malignancies or lymphomas refractory to standard treatment or for which no standard treatment is…NCT01588678·San Antonio, Texas

Active not recruitingCD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLLPatients on this study have a type of lymph gland cancer called non-Hodgkin Lymphoma, Acute Lymphocytic Leukemia, or chronic Lymphocytic Leukemia (these diseases will be referred…NCT00586391·Houston, Texas and 1 other

Other Conditions in Texas

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia